近20多年来,心力衰竭已成为危害人类健康的主要疾病之一,尽管近年来以血管紧张素转换酶抑制剂(ACEI)和(受体阻滞剂为首的药物治疗取得了可喜的成绩,但是心力衰竭患者长期生存率仍然较低。近年来,心脏再同步治疗(CRT)已成为慢性心力衰竭非药物治疗的热点,受到越来越多的关注。 For more than 20 years, heart failure has become one of the major diseases endangering human health. Although angiotensin converting enzyme inhibitors (ACE inhibitors) and (blockers) -mediated drug treatment have made gratifying achievements in recent years, Long-term survival of patients with heart failure is still low. In recent years, cardiac resynchronization therapy (CRT) has become a hot non-drug treatment of chronic heart failure, more and more attention.